Fanyu Bu

Ms. Fanyu Bu

BGI Research, Shenzhen, Guangdong, China
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2022 in Cancers
Verified
Journal Article
Open access
PDF file
HXHaitao Xiang
Haitao Xiang
LZLe Zhang
Le Zhang
FBFanyu Bu
Fanyu Bu
XGxiangyu Guan
xiangyu Guan
LCLei Chen
Lei Chen
XDXuan DONG
Xuan DONG
Tumor-specific antigens can activate T cell-based antitumor immune responses and are ideal targets for cancer immunotherapy. However, their identification is still challenging. Although mass spectrometry can directly identify human leukocyte antigen (HLA) binding peptides in tumor cells, it focuses on tumor-specific antigens derived from annotated protein-coding regions constituting only 1.5% of the genome. We developed a novel proteogenomic integration strategy to expand the breadth of tumor-specific epitopes derived from all genomic regions. Using the colorectal cancer cell line HCT116 as a model, we accurately identified 10,737 HLA-presented peptides, 1293 of which were non-canonical peptides that traditional database searches could not identify. Moreover, we found eight tumor neo-epitopes derived from somatic mutations, four of which were not previously reported. Our findings suggest that this new proteogenomic approach holds great promise for increasing the number of tumor-specific antigen candidates, potentially enlarging the tumor target pool and improving cancer immunotherapy.

10 June 2023 in Analytical Chemistry
Verified
Journal Article
Closed access
YLYijian Li
Yijian Li
JQJingyu Qi
Jingyu Qi
YLYang Liu
Yang Liu
YZYuyu Zheng
Yuyu Zheng
HZHaibin Zhu
Haibin Zhu
YLYa Liu
Ya Liu

8 November 2021 in Journal of Proteome Research
Verified
Journal Article
Closed access
FBFanyu Bu
Fanyu Bu
QCQingqiu Cheng
Qingqiu Cheng
YZYuxing Zhang
Yuxing Zhang
XZXia Zhang
Xia Zhang
KYKeqiang Yan
Keqiang Yan
SLSiqi Liu
Siqi Liu